Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

95.73
Delayed Data
As of Sep 26
 -1.67 / -1.71%
Today’s Change
82.50
Today|||52-Week Range
167.92
-33.84%
Year-to-Date
Perrigo Could Rake In $2.8 Billion in Tysabri Divestitures, Analysts Say
Sep 20 / TheStreet.com - Paid Partner Content
Company News for September 13, 2016
Sep 13 / Zacks.com - Paid Partner Content
Inside the Recent Surge in Biotech ETFs
Sep 14 / Zacks.com - Paid Partner Content
Perrigo shares jump as activist Starboard's stake revealed
Sep 12 / FT.com - Paid Partner Content
Perrigo Up as Starboard Reveals Stake, Changes Proposed
Sep 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close97.40
Today’s open96.65
Day’s range95.21 - 96.76
Volume1,017,915
Average volume (3 months)2,301,712
Market cap$14.0B
Dividend yield0.61%
Data as of 4:02pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+36.36%
P/E ratio20.2
Price/Sales3.82
Price/Book1.39

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc0.000.00%
BMRNBiomarin Pharmaceuti...-1.53-1.57%
INCYIncyte Corp-0.22-0.25%
VRXValeant Pharmaceutic...-1.83-6.60%
Data as of 4:01pm ET, 09/26/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$1.59
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Executive VP, Chief Financial &
Accounting Officer
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts

Search for Jobs